Tumori Journal - TJ
@tumorijournal.bsky.social
Tumori Journal #TJ is an international peer-reviewed journal that publishes updates in #oncology thanks contributions by opinion leaders and emerging researchers.
#OncSky #MedSky
https://journals.sagepub.com/home/TMJ
#OncSky #MedSky
https://journals.sagepub.com/home/TMJ
👉Choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on validating surrogate endpoints and biomarkers
Learn more omny.fm/shows/tumori...
Learn more omny.fm/shows/tumori...
November 27, 2025 at 12:15 PM
👉Choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on validating surrogate endpoints and biomarkers
Learn more omny.fm/shows/tumori...
Learn more omny.fm/shows/tumori...
🤔 What would happen if admissions for which a long hospital stay is recommended were planned from the moment patients are admitted?❓
🏥In a context of bed shortage and increasing healthcare costs, promoting actions that contain hospital stay is a priority.
journals.sagepub.com/share/PTRK6J...
🏥In a context of bed shortage and increasing healthcare costs, promoting actions that contain hospital stay is a priority.
journals.sagepub.com/share/PTRK6J...
November 24, 2025 at 2:51 PM
🤔 What would happen if admissions for which a long hospital stay is recommended were planned from the moment patients are admitted?❓
🏥In a context of bed shortage and increasing healthcare costs, promoting actions that contain hospital stay is a priority.
journals.sagepub.com/share/PTRK6J...
🏥In a context of bed shortage and increasing healthcare costs, promoting actions that contain hospital stay is a priority.
journals.sagepub.com/share/PTRK6J...
#Surgery | Uniportal 3D VATS lobectomy demonstrates clear advantages over traditional 2D VATS lobectomy for #NSCLC patients by reducing perioperative pain, minimizing immune impairment, and preserving lung function.
journals.sagepub.com/share/ZEANWY...
#lungcancer
journals.sagepub.com/share/ZEANWY...
#lungcancer
November 22, 2025 at 5:30 PM
#Surgery | Uniportal 3D VATS lobectomy demonstrates clear advantages over traditional 2D VATS lobectomy for #NSCLC patients by reducing perioperative pain, minimizing immune impairment, and preserving lung function.
journals.sagepub.com/share/ZEANWY...
#lungcancer
journals.sagepub.com/share/ZEANWY...
#lungcancer
Thyroid cancer is the most common endocrine malignancy in the world including in #Turkey
👇
Etlik City Hospital, Ankara study | Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary #thyroidcancer❓
journals.sagepub.com/doi/full/10....
👇
Etlik City Hospital, Ankara study | Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary #thyroidcancer❓
journals.sagepub.com/doi/full/10....
November 21, 2025 at 4:30 PM
Thyroid cancer is the most common endocrine malignancy in the world including in #Turkey
👇
Etlik City Hospital, Ankara study | Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary #thyroidcancer❓
journals.sagepub.com/doi/full/10....
👇
Etlik City Hospital, Ankara study | Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary #thyroidcancer❓
journals.sagepub.com/doi/full/10....
Find out how #liquidbiopsy is absolutely the new goal of #precisiononcology, capable of technologically and culturally revolutionising clinical practice, in this TJ Talks podcast with prof. Andrea Sartore Bianchi, leading expert in #colorectalcancer #CRCSM🩸🧪🧬
t.co/mm03GTJRT6
t.co/mm03GTJRT6
November 21, 2025 at 4:10 PM
Find out how #liquidbiopsy is absolutely the new goal of #precisiononcology, capable of technologically and culturally revolutionising clinical practice, in this TJ Talks podcast with prof. Andrea Sartore Bianchi, leading expert in #colorectalcancer #CRCSM🩸🧪🧬
t.co/mm03GTJRT6
t.co/mm03GTJRT6
👉 FoundationOne®CDx provides an accurate assessment of ERBB2 copy number status and may be a cost-effective option in patients with metastatic cancer for whom #NGS testing is recommended.
Read more about this study at the link
journals.sagepub.com/share/UCJJ4G...
#CanSky
Read more about this study at the link
journals.sagepub.com/share/UCJJ4G...
#CanSky
November 21, 2025 at 11:00 AM
👉 FoundationOne®CDx provides an accurate assessment of ERBB2 copy number status and may be a cost-effective option in patients with metastatic cancer for whom #NGS testing is recommended.
Read more about this study at the link
journals.sagepub.com/share/UCJJ4G...
#CanSky
Read more about this study at the link
journals.sagepub.com/share/UCJJ4G...
#CanSky
🗣️Scarcity of resources, insufficient authority: reform of Italian Ethics Committees aimed to simplify ethical oversight in #clinicalresearch
👇
Gaps remain in implementation and limited mandate of ECs excludes much ethically complex but unregulated research.
journals.sagepub.com/doi/10.1177/...
👇
Gaps remain in implementation and limited mandate of ECs excludes much ethically complex but unregulated research.
journals.sagepub.com/doi/10.1177/...
November 20, 2025 at 3:20 PM
🗣️Scarcity of resources, insufficient authority: reform of Italian Ethics Committees aimed to simplify ethical oversight in #clinicalresearch
👇
Gaps remain in implementation and limited mandate of ECs excludes much ethically complex but unregulated research.
journals.sagepub.com/doi/10.1177/...
👇
Gaps remain in implementation and limited mandate of ECs excludes much ethically complex but unregulated research.
journals.sagepub.com/doi/10.1177/...
📢In TJ, just out the #AbstractBook of the Italian Association of Medical Oncology (AIOM) Congress 2025, 07-09 November 2025❗
🆓Browse through the 500 abstracts from the #AIOM2025 in the e-pub version here journals.sagepub.com/doi/epub/10....
@oncoalert.bsky.social #CanSky #OncoSky
🆓Browse through the 500 abstracts from the #AIOM2025 in the e-pub version here journals.sagepub.com/doi/epub/10....
@oncoalert.bsky.social #CanSky #OncoSky
November 13, 2025 at 6:01 PM
📢In TJ, just out the #AbstractBook of the Italian Association of Medical Oncology (AIOM) Congress 2025, 07-09 November 2025❗
🆓Browse through the 500 abstracts from the #AIOM2025 in the e-pub version here journals.sagepub.com/doi/epub/10....
@oncoalert.bsky.social #CanSky #OncoSky
🆓Browse through the 500 abstracts from the #AIOM2025 in the e-pub version here journals.sagepub.com/doi/epub/10....
@oncoalert.bsky.social #CanSky #OncoSky
🥊Researchers as gladiators in the “publish or perish” arena instead of appreciating their competence.
#OpenScience would help to reform this unhealthy system of evaluation (perhaps with #AI to support peer review🤖...).
Very impressive insights, thank you all❗️
#AIOM2025 and TJ - Round Table
#OpenScience would help to reform this unhealthy system of evaluation (perhaps with #AI to support peer review🤖...).
Very impressive insights, thank you all❗️
#AIOM2025 and TJ - Round Table
November 12, 2025 at 2:37 PM
🥊Researchers as gladiators in the “publish or perish” arena instead of appreciating their competence.
#OpenScience would help to reform this unhealthy system of evaluation (perhaps with #AI to support peer review🤖...).
Very impressive insights, thank you all❗️
#AIOM2025 and TJ - Round Table
#OpenScience would help to reform this unhealthy system of evaluation (perhaps with #AI to support peer review🤖...).
Very impressive insights, thank you all❗️
#AIOM2025 and TJ - Round Table
📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
November 4, 2025 at 11:29 AM
📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
🗣️ This is the first prospective study conducted on patients with mRCC, previously treated with nivolumab plus metformin, which shows that the combination has limited clinical activity and does not improve progression-free survival.
journals.sagepub.com/share/ISAWAM...
#livercancer #HCC
journals.sagepub.com/share/ISAWAM...
#livercancer #HCC
November 4, 2025 at 11:00 AM
🗣️ This is the first prospective study conducted on patients with mRCC, previously treated with nivolumab plus metformin, which shows that the combination has limited clinical activity and does not improve progression-free survival.
journals.sagepub.com/share/ISAWAM...
#livercancer #HCC
journals.sagepub.com/share/ISAWAM...
#livercancer #HCC
📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
@paolocrosetto.bsky.social
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
@paolocrosetto.bsky.social
November 2, 2025 at 5:01 PM
📅 8 NOV | #Ethics in the evaluation of scientific research quality.
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
@paolocrosetto.bsky.social
AIOM and Tumori Journal reflect on an issue that seems to be urgent for scientific community. Meet the outstanting panel, join the discussion!😀
📌XXVII AIOM Congress, Rome congresso.aiom.it
@paolocrosetto.bsky.social
Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid #leukemia
journals.sagepub.com/share/TXZC4Y...
@LeukemiaRF @LLSCanada
journals.sagepub.com/share/TXZC4Y...
@LeukemiaRF @LLSCanada
October 31, 2025 at 11:02 AM
Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid #leukemia
journals.sagepub.com/share/TXZC4Y...
@LeukemiaRF @LLSCanada
journals.sagepub.com/share/TXZC4Y...
@LeukemiaRF @LLSCanada
October 30, 2025 at 11:01 AM
🏥 Etlik City Hospital, Ankara, #Turkey➡️ Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer❓
journals.sagepub.com/share/GHVJPJ...
journals.sagepub.com/share/GHVJPJ...
October 28, 2025 at 2:00 PM
🏥 Etlik City Hospital, Ankara, #Turkey➡️ Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer❓
journals.sagepub.com/share/GHVJPJ...
journals.sagepub.com/share/GHVJPJ...
🗣️The system for evaluating the #Off-Label use of cancer drugs is highly fragmented, with consequences for #equity and clinical efficiency
👇
Addressing the problem requires coordinated action at institutional levels. Possibly involving medical #oncologists
journals.sagepub.com/doi/epub/10....
👇
Addressing the problem requires coordinated action at institutional levels. Possibly involving medical #oncologists
journals.sagepub.com/doi/epub/10....
October 23, 2025 at 1:27 PM
🗣️The system for evaluating the #Off-Label use of cancer drugs is highly fragmented, with consequences for #equity and clinical efficiency
👇
Addressing the problem requires coordinated action at institutional levels. Possibly involving medical #oncologists
journals.sagepub.com/doi/epub/10....
👇
Addressing the problem requires coordinated action at institutional levels. Possibly involving medical #oncologists
journals.sagepub.com/doi/epub/10....
💥Integration of #LiquidBiopsy into a diagnostic algorithm
enables broader access to BRCA1/2 stratification and supports timely PARP inhibitor therapy
This #consensus aims to improve diagnostic consistency and clinical outcomes in #mCRPC management
journals.sagepub.com/share/HUFFX4...
#pcsm
enables broader access to BRCA1/2 stratification and supports timely PARP inhibitor therapy
This #consensus aims to improve diagnostic consistency and clinical outcomes in #mCRPC management
journals.sagepub.com/share/HUFFX4...
#pcsm
October 17, 2025 at 2:59 PM
💥Integration of #LiquidBiopsy into a diagnostic algorithm
enables broader access to BRCA1/2 stratification and supports timely PARP inhibitor therapy
This #consensus aims to improve diagnostic consistency and clinical outcomes in #mCRPC management
journals.sagepub.com/share/HUFFX4...
#pcsm
enables broader access to BRCA1/2 stratification and supports timely PARP inhibitor therapy
This #consensus aims to improve diagnostic consistency and clinical outcomes in #mCRPC management
journals.sagepub.com/share/HUFFX4...
#pcsm
🌟Tumori Journal Gastrointestinal Oncology Section is devoted to publish the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.
No FEE to Publish in TJ!
Section Editors' bio-sketchs👇
tumorijournal.org/about-us/#ed...
No FEE to Publish in TJ!
Section Editors' bio-sketchs👇
tumorijournal.org/about-us/#ed...
October 14, 2025 at 4:33 PM
🌟Tumori Journal Gastrointestinal Oncology Section is devoted to publish the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care.
No FEE to Publish in TJ!
Section Editors' bio-sketchs👇
tumorijournal.org/about-us/#ed...
No FEE to Publish in TJ!
Section Editors' bio-sketchs👇
tumorijournal.org/about-us/#ed...
"October is #BreastCancerAwarenessMonth, honouring millions of lives affected by breast cancer and reaffirm our global commitment to equitable access to care and improved survival for all." (WHO)
The #BreastCancer TJ Section Editors work on that 🎯
Visit link for SE's bio-sketchs t.co/arHPylNIcr
The #BreastCancer TJ Section Editors work on that 🎯
Visit link for SE's bio-sketchs t.co/arHPylNIcr
October 8, 2025 at 11:01 AM
"October is #BreastCancerAwarenessMonth, honouring millions of lives affected by breast cancer and reaffirm our global commitment to equitable access to care and improved survival for all." (WHO)
The #BreastCancer TJ Section Editors work on that 🎯
Visit link for SE's bio-sketchs t.co/arHPylNIcr
The #BreastCancer TJ Section Editors work on that 🎯
Visit link for SE's bio-sketchs t.co/arHPylNIcr
💥Tumori Journal issue just out💥
Starting with an editorial by AIOM, the contents offer a broad overview of the most current and innovative topics in #oncology, covered by renowned researchers in the field.
Learn more journals.sagepub.com/toc/tmja/111...
#CanSky @oncoalert.bsky.social
Starting with an editorial by AIOM, the contents offer a broad overview of the most current and innovative topics in #oncology, covered by renowned researchers in the field.
Learn more journals.sagepub.com/toc/tmja/111...
#CanSky @oncoalert.bsky.social
October 6, 2025 at 2:38 PM
💥Tumori Journal issue just out💥
Starting with an editorial by AIOM, the contents offer a broad overview of the most current and innovative topics in #oncology, covered by renowned researchers in the field.
Learn more journals.sagepub.com/toc/tmja/111...
#CanSky @oncoalert.bsky.social
Starting with an editorial by AIOM, the contents offer a broad overview of the most current and innovative topics in #oncology, covered by renowned researchers in the field.
Learn more journals.sagepub.com/toc/tmja/111...
#CanSky @oncoalert.bsky.social
💥This study contributes to the ongoing efforts to develop more personalized Normal Tissue Complication Probability (NTCP) models by incorporating patient-specific factors that may explain different responses to #radiotherapy dose.
journals.sagepub.com/share/A95GPU...
#RadOnc
journals.sagepub.com/share/A95GPU...
#RadOnc
October 2, 2025 at 2:43 PM
💥This study contributes to the ongoing efforts to develop more personalized Normal Tissue Complication Probability (NTCP) models by incorporating patient-specific factors that may explain different responses to #radiotherapy dose.
journals.sagepub.com/share/A95GPU...
#RadOnc
journals.sagepub.com/share/A95GPU...
#RadOnc
💥Prof. Paolo Marchetti is the promoter of Trial of ROME clinical study and first author of #Nature groundbreaking paper on that.
In this #TJTalks about #PrecisionOncology and key aspects of the ROME study, he talks with Prof. Pruneri,
TJ EiC.
🎧 omny.fm/shows/tumori...
#CanSky #Oncosky
In this #TJTalks about #PrecisionOncology and key aspects of the ROME study, he talks with Prof. Pruneri,
TJ EiC.
🎧 omny.fm/shows/tumori...
#CanSky #Oncosky
October 1, 2025 at 1:02 PM
💥Prof. Paolo Marchetti is the promoter of Trial of ROME clinical study and first author of #Nature groundbreaking paper on that.
In this #TJTalks about #PrecisionOncology and key aspects of the ROME study, he talks with Prof. Pruneri,
TJ EiC.
🎧 omny.fm/shows/tumori...
#CanSky #Oncosky
In this #TJTalks about #PrecisionOncology and key aspects of the ROME study, he talks with Prof. Pruneri,
TJ EiC.
🎧 omny.fm/shows/tumori...
#CanSky #Oncosky
#CaseReport | Metastatic recurrence OR onset of a second primary malignancy❓
#PrecisionMedicine can offer valuable support in diagnosis👇
#Breastcancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report
journals.sagepub.com/share/U56Y6Z...
#cansky #oncosky
#PrecisionMedicine can offer valuable support in diagnosis👇
#Breastcancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report
journals.sagepub.com/share/U56Y6Z...
#cansky #oncosky
September 24, 2025 at 12:53 PM
#CaseReport | Metastatic recurrence OR onset of a second primary malignancy❓
#PrecisionMedicine can offer valuable support in diagnosis👇
#Breastcancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report
journals.sagepub.com/share/U56Y6Z...
#cansky #oncosky
#PrecisionMedicine can offer valuable support in diagnosis👇
#Breastcancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report
journals.sagepub.com/share/U56Y6Z...
#cansky #oncosky
💡 Do you have groundbreaking research to publish, or a topic on the latest trends in oncology for a #TJTalks #podcast❓
Contact us tumorijournal.org/contact-us/
✍ Fill out the form with a brief presentation of the topic you suggest. We will be happy to receive your valuable contribution 😀
Contact us tumorijournal.org/contact-us/
✍ Fill out the form with a brief presentation of the topic you suggest. We will be happy to receive your valuable contribution 😀
September 22, 2025 at 3:07 PM
💡 Do you have groundbreaking research to publish, or a topic on the latest trends in oncology for a #TJTalks #podcast❓
Contact us tumorijournal.org/contact-us/
✍ Fill out the form with a brief presentation of the topic you suggest. We will be happy to receive your valuable contribution 😀
Contact us tumorijournal.org/contact-us/
✍ Fill out the form with a brief presentation of the topic you suggest. We will be happy to receive your valuable contribution 😀
#MeetTheEditors We are pleased to introduce Gynecologic Oncology Section and its Editors.
This section, led by prof. D Lorusso and prof. F Peccatori
, is devoted to the evaluation of research articles on pioneering treatments for Gynecologic cancer
SE's bio-sketchs
journals.sagepub.com/home/tmj
This section, led by prof. D Lorusso and prof. F Peccatori
, is devoted to the evaluation of research articles on pioneering treatments for Gynecologic cancer
SE's bio-sketchs
journals.sagepub.com/home/tmj
September 11, 2025 at 1:16 PM
#MeetTheEditors We are pleased to introduce Gynecologic Oncology Section and its Editors.
This section, led by prof. D Lorusso and prof. F Peccatori
, is devoted to the evaluation of research articles on pioneering treatments for Gynecologic cancer
SE's bio-sketchs
journals.sagepub.com/home/tmj
This section, led by prof. D Lorusso and prof. F Peccatori
, is devoted to the evaluation of research articles on pioneering treatments for Gynecologic cancer
SE's bio-sketchs
journals.sagepub.com/home/tmj